butenafine has been researched along with Leishmaniasis, American in 1 studies
butenafine: studied on experimental dermatophytosis
butenafine : Trimethylamine in which hydrogen atoms attached to different methyl groups are substituted by 1-naphthyl and 4-tert-butylphenyl groups. It is an inhibitor of squalene epoxidase, an enzyme responsible for the creation of sterols needed in fungal cell membranes, and is used as its hydrochloride salt for treatment of dermatological fungal infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bezerra-Souza, A | 1 |
| Jesus, JA | 1 |
| Laurenti, MD | 1 |
| Lalatsa, A | 1 |
| Serrano, DR | 1 |
| Passero, LFD | 1 |
1 other study available for butenafine and Leishmaniasis, American
| Article | Year |
|---|---|
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Antifungal Agents; Benzylamines; Drug De | 2021 |